The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Johannes C. Kelder
Showing 1-8 of 8 articles
Impact of mitral valve treatment choice on mortality according to aetiology
Kortlandt F,
Velu J,
Schurer R,
Van den Branden B,
Bouma B,
Kelder J,
Eefting F,
Swaans MJ,
Rensing B,
Baan Jr J,
Van der Heyden J
April 16, 2019 | 10.4244/EIJ-D-18-00874
Optical coherence tomography findings: insights from the “randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions” (PRISON IV) trial
Teeuwen K,
Spoormans E,
Bennett J,
Dubois C,
Desmet W,
Ughi G,
Belmans A,
Kelder J,
Tijssen J,
Agostoni P,
Suttorp MJ,
Adriaenssens T
August 4, 2017 | 10.4244/EIJ-D-17-00261
Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial
Dewilde W,
Janssen P,
Kelder J,
Verheugt F,
de Smet B,
Adriaenssens T,
Vrolix M,
Brueren G,
Vandendriessche T,
van Mieghem C,
Cornelis K,
Vos J,
Breet N,
ten Berg J
August 20, 2015 | 10.4244/EIJY14M06_07
Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Teeuwen K,
Van den Branden B,
Koolen J,
van der Schaaf RJ,
Henriques J,
Thijssen J,
Kelder J,
Vermeersch P,
Rensing B,
Suttorp MJ
March 20, 2015 | 10.4244/EIJY14M08_07
Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III): a randomised comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Van den Branden B,
Teeuwen K,
Koolen J,
van der Schaaf RJ,
Henriques J,
Thijssen J,
Kelder J,
Vermeersch P,
Rensing B,
Suttorp MJ
November 29, 2013 | 10.4244/EIJV9I7A138
Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II)
Teeuwen K,
Van den Branden B,
Rahel B,
Laarman G,
Thijssen J,
Kelder J,
Slagboom T,
ten Berg J,
Suttorp MJ
June 28, 2013 | 10.4244/EIJV9I2A36
Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study)
Van den Branden B,
Rahel B,
Laarman G,
Slagboom T,
Kelder J,
ten Berg J,
Suttorp MJ
February 21, 2012 | 10.4244/EIJV7I10A190
Triggering mechanisms of stent thrombosis
Zwart B,
van Werkum J,
Heestermans A,
Kelder J,
Zomer A,
van't Hof A,
Verheugt F,
ten Berg J
January 20, 2011
1
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke